Price$94.06-10.50 (-10.05%)
2026-03-042026-06-05
News · 26 weeks42-50%
2025-12-142026-06-07
Mix2390d
- Insider14(61%)
- Other4(17%)
- SEC Filings3(13%)
- Earnings2(9%)
Latest news
25 items- INSIDERDirector Scharen-Guivel Hilda Frederique sold $285,000 worth of shares (3,000 units at $95.00), decreasing direct ownership by 35% to 5,598 units (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, President, Chairman Susi Roger E. sold $226,507 worth of shares (2,500 units at $90.60) as part of a pre-agreed trading plan (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, President, Chairman Susi Roger E. sold $691,044 worth of shares (7,500 units at $92.14) as part of a pre-agreed trading plan (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, President, Chairman Susi Roger E. sold $657,265 worth of shares (7,500 units at $87.64) as part of a pre-agreed trading plan (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- PRIRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare ConferenceORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida. Investors interested in meeting with Iradimed management during the conference may contact their Goldman Sachs representative to schedule a one-on-one meeting. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ("MRI"
- SECAmendment: SEC Form SCHEDULE 13G/A filed by iRadimed CorporationSCHEDULE 13G/A - IRADIMED CORP (0001325618) (Subject)
- INSIDERCEO, President, Chairman Susi Roger E. sold $631,341 worth of shares (7,500 units at $84.18) as part of a pre-agreed trading plan (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, President, Chairman Susi Roger E. sold $642,862 worth of shares (7,500 units at $85.71) as part of a pre-agreed trading plan (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- SECSEC Form 10-Q filed by iRadimed Corporation10-Q - IRADIMED CORP (0001325618) (Filer)
- SECiRadimed Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - IRADIMED CORP (0001325618) (Filer)
- PRIRADIMED CORPORATION Reports First Quarter 2026 Financial ResultsAnnounces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $22.0 million for the first quarter of 2026, an increase of $2.5 million, or 13%, compared to the same period in 2025.Reports record GAAP diluted EPS of $0.45 and non-GAAP diluted EPS of $0.49 for the first quarter of 2026, which are increases of 22% and 17%, respectively, compared to the same period in 2025.Declares a regular quarterly cash dividend of $0.20 per share of common stock for the second quarter of 2026, payable on May 29, 2026. ORLANDO, Fla., May 01, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company" or "Iradimed") (NASDAQ:IRMD)
- SECSEC Form DEF 14A filed by iRadimed CorporationDEF 14A - IRADIMED CORP (0001325618) (Filer)
- INSIDERCEO, President, Chairman Susi Roger E. sold $657,709 worth of shares (7,500 units at $87.69) as part of a pre-agreed trading plan (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- PRIRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.com/register/BI7676b33322324840ad2b154cc8e65b88. Once registered, a dial-in number, unique pin, and instructions will be provided to participants. The conference call will also be available real-time
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- PRIRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare ConferenceORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference. Iradimed's CFO, Jack Glenn, will host one-on-one meetings with investors at the 25th Annual Needham Virtual Healthcare Conference, which is scheduled to take place from April 13-16, 2026. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the only known provider of a non-magneti
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- PRIRADIMED CORPORATION to Participate at the 38th Annual Roth ConferenceORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) today announced that it will participate in the 38th Annual Roth Conference. Iradimed's CEO, Roger Susi, and CFO, Jack Glenn, will host one-on-one meetings between company management and investors at the 38th Annual Roth Conference, which will be held at the Ritz-Carlton in Laguna Niguel, CA, on March 22 and 24, 2026. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the onl
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $750,475 worth of shares (7,500 units at $100.06) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $737,919 worth of shares (7,500 units at $98.39) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- SECSEC Form 10-K filed by iRadimed Corporation10-K - IRADIMED CORP (0001325618) (Filer)
IRMD FAQ
7 questionsWhat does iRadimed Corporation do?
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute...Where does IRMD stock trade?
iRadimed Corporation (IRMD) is listed on NASDAQ.What sector and industry is IRMD in?
iRadimed Corporation operates in the Health Care sector, Medical/Dental Instruments industry.When did iRadimed Corporation go public?
iRadimed Corporation (IRMD) completed its IPO in 2014.What are analysts saying about IRMD?
iRadimed Corporation has had 1 recent analyst action on file. The most recent action was from Lake Street: Buy on 2023-04-12.What companies are similar to IRMD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare IRMD side-by-side with any of them on Quantisnow.How can I track IRMD on Quantisnow?
Quantisnow aggregates iRadimed Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IRMD to receive live email and push alerts on every new disclosure.